Michael B. Bober

Michael B. Bober

Auto-generated profile, based on publicly available information

Michael B. Bober

Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MWMichael P. Whyte
Michael P. Whyte
CGCheryl R. Greenberg
Cheryl R. Greenberg
NSNada J. Salman
Nada J. Salman
MBMichael B. Bober
Michael B. Bober
WMWilliam H. McAlister
William H. McAlister
HLHal Landy
Hal Landy
Hypophosphatasia results from mutations in the gene for the tissue-nonspecific isozyme of alkaline phosphatase (TNSALP). Inorganic pyrophosphate accumulates extracellularly, leading to rickets or osteomalacia. Severely affected babies often die from respiratory insufficiency due to progressive chest deformity or have persistent bone disease. There is no approved medical therapy. ENB-0040 is a bone-targeted, recombinant human TNSALP that prevents the manifestations of hypophosphatasia in Tnsalp knockout mice.

27 February 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LBLouise S Bicknell
Louise S Bicknell
EBErnie M H F Bongers
Ernie M H F Bongers
ALAndrea Leitch
Andrea Leitch
SBStephen Brown
Stephen Brown
JSJeroen Schoots
Jeroen Schoots
AJAndrew P Jackson
Andrew P Jackson
Andrew Jackson, Ernie Bongers and colleagues report the identification of mutations in five genes in individuals with Meier-Gorlin syndrome. The five genes, ORC1, ORC4, ORC6, CDT1 and CDC6, all encode components of the pre-replication complex. Meier-Gorlin syndrome (ear, patella and short-stature syndrome) is an autosomal recessive primordial dwarfism syndrome characterized by absent or hypoplastic patellae and markedly small ears1,2,3. Both pre- and post-natal growth are impaired in this disorder, and although microcephaly is often evident, intellect is usually normal in this syndrome. We report here that individuals with this disorder show marked locus heterogeneity, and we identify mutations in five separate genes: ORC1, ORC4, ORC6, CDT1 and CDC6. All of these genes encode components of the pre-replication complex, implicating defects in replication licensing as the cause of a genetic syndrome with distinct developmental abnormalities.

8 April 2011 in Science
Verified
Journal Article
Closed access
PDF file
PEPatrick Edery
Patrick Edery
CMCharles Marcaillou
Charles Marcaillou
MSMourad Sahbatou
Mourad Sahbatou
ALAudrey Labalme
Audrey Labalme
JCJoelle Chastang
Joelle Chastang
ALAnne-Louise Leutenegger
Anne-Louise Leutenegger
The spliceosome, a ribonucleoprotein complex that includes proteins and small nuclear RNAs (snRNAs), catalyzes RNA splicing through intron excision and exon ligation to produce mature messenger RNAs, which, in turn serve as templates for protein translation. We identified four point mutations in the U4atac snRNA component of the minor spliceosome in patients with brain and bone malformations and unexplained postnatal death [microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) or Taybi-Linder syndrome (TALS); Mendelian Inheritance in Man ID no. 210710]. Expression of a subgroup of genes, possibly linked to the disease phenotype, and minor intron splicing were affected in cell lines derived from TALS patients. Our findings demonstrate a crucial role of the minor spliceosome component U4atac snRNA in early human development and postnatal survival.

27 February 2011 in Nature Genetics
Verified
Journal Article
Closed access
LBLouise S Bicknell
Louise S Bicknell
SWSarah Walker
Sarah Walker
AKAnna Klingseisen
Anna Klingseisen
TSTom Stiff
Tom Stiff
ALAndrea Leitch
Andrea Leitch
PJPenny A Jeggo
Penny A Jeggo

1 October 2016 in Genes & Development
Verified
Journal Article
Open access
PDF file
CMCarol-Anne Martin
Carol-Anne Martin
JMJennie E. Murray
Jennie E. Murray
PCPaula Carroll
Paula Carroll
ALAndrea Leitch
Andrea Leitch
KMKaren J. Mackenzie
Karen J. Mackenzie
AJAndrew P. Jackson
Andrew P. Jackson
Compaction of chromosomes is essential for accurate segregation of the genome during mitosis. In vertebrates, two condensin complexes ensure timely chromosome condensation, sister chromatid disentanglement, and maintenance of mitotic chromosome structure. Here, we report that biallelic mutations in NCAPD2, NCAPH, or NCAPD3, encoding subunits of these complexes, cause microcephaly. In addition, hypomorphic Ncaph2 mice have significantly reduced brain size, with frequent anaphase chromatin bridge formation observed in apical neural progenitors during neurogenesis. Such DNA bridges also arise in condensin-deficient patient cells, where they are the consequence of failed sister chromatid disentanglement during chromosome compaction. This results in chromosome segregation errors, leading to micronucleus formation and increased aneuploidy in daughter cells. These findings establish “condensinopathies” as microcephalic disorders, with decatenation failure as an additional disease mechanism for microcephaly, implicating mitotic chromosome condensation as a key process ensuring mammalian cerebral cortex size.

15 February 2012 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
SMSonja A de Munnik
Sonja A de Munnik
LBLouise S Bicknell
Louise S Bicknell
SASalim Aftimos
Salim Aftimos
JAJumana Y Al-Aama
Jumana Y Al-Aama
YBYolande van Bever
Yolande van Bever
EBErnie M H F Bongers
Ernie M H F Bongers
Meier–Gorlin syndrome (MGS) is an autosomal recessive disorder characterized by microtia, patellar aplasia/hypoplasia, and short stature. Recently, mutations in five genes from the pre-replication complex (ORC1, ORC4, ORC6, CDT1, and CDC6), crucial in cell-cycle progression and growth, were identified in individuals with MGS. Here, we report on genotype–phenotype studies in 45 individuals with MGS (27 females, 18 males; age 3 months–47 years). Thirty-five individuals had biallelic mutations in one of the five causative pre-replication genes. No homozygous or compound heterozygous null mutations were detected. In 10 individuals, no definitive molecular diagnosis was made. The triad of microtia, absent/hypoplastic patellae, and short stature was observed in 82% of individuals with MGS. Additional frequent clinical features were mammary hypoplasia (100%) and abnormal genitalia (42%; predominantly cryptorchidism and hypoplastic labia minora/majora). One individual with ORC1 mutations only had short stature, emphasizing the highly variable clinical spectrum of MGS. Individuals with ORC1 mutations had significantly shorter stature and smaller head circumferences than individuals from other gene categories. Furthermore, compared with homozygous missense mutations, compound heterozygous mutations appeared to have a more severe effect on phenotype, causing more severe growth retardation in ORC4 and more frequently pulmonary emphysema in CDT1. A lethal phenotype was seen in four individuals with compound heterozygous ORC1 and CDT1 mutations. No other clear genotype–phenotype association was observed. Growth hormone and estrogen treatment may be of some benefit, respectively, to growth retardation and breast hypoplasia, though further studies in this patient group are needed.